Muteins of clotting factor VIII
Abstract:
The present disclosure provides muteins of FVIII to which a biocompatible polymer may be attached to increase the circulatory half-life of the muteins, as well as conjugates of such muteins and biocompatible polymers.
Public/Granted literature
Information query
Patent Agency Ranking
0/0